Smith Group Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-33,130
Closed -$2.23M 176
2025
Q3
$2.23M Hold
33,130
0.13% 60
2025
Q2
$2.89M Sell
33,130
-8,870
-21% -$695K 0.19% 50
2025
Q1
$2.87M Hold
42,000
0.22% 52
2024
Q4
$3.27M Buy
+42,000
New +$3.11M 0.24% 52
2024
Q2
Sell
-81,000
Closed -$11.2M 153
2024
Q1
$11.2M Sell
81,000
-33,200
-29% -$4.17M 0.64% 55
2023
Q4
$14.2M Buy
+114,200
New +$11.7M 0.82% 51

Other funds holding DXCM

Smith Group Asset Management's DXCM Position: Q4 2025 in Review

Smith Group Asset Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 33,130 shares — an estimated $2.23M sold.

Smith Group Asset Management first reported a position in DXCM in Q4 2023 and held it in 6 quarters. The position peaked at $14.2M in Q4 2023. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Smith Group Asset Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Smith Group Asset Management sold 33,130 DexCom shares in Q4 2025, an estimated $2.23M.
  • Smith Group Asset Management first reported a position in DexCom in Q4 2023 and held it in 6 quarters.
  • Smith Group Asset Management's DexCom position peaked at $14.2M in Q4 2023.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Smith Group Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.